Evidence map›Paper›PMID 27513465›Full record

ArticlePloS one2016

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition.

Yun Zhou, Yongwen Huang, Xinping Cao, Jing Xu, Lan Zhang, Jianhua Wang, Long Huang, Shuting Huang, Linjing Yuan, Weihua Jia and 3 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Unleashing Wnts: Wnt Ligands Fuel Cancer Spread.Journal of cancer biology · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yun ZhouDepartment of Gynecology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.ORCID http://orcid.org/0000-0002-6255-301X
Yongwen HuangDepartment of Gynecology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Xinping CaoDepartment of Radiotherapy, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Jing XuState Key Laboratory of Oncology in South China, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Lan ZhangDepartment of Gynecology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Jianhua WangCardiovascular Department, Second People's Hospital of Guangdong Province, 1 Shi-liu gang Road East, Guangzhou, 510317, P. R. China.
Long HuangDepartment of Oncology, the Second Affiliated Hospital, Nanchang University, Nanchang, 330000, P. R. China.
Shuting HuangDepartment of Gynecology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Linjing YuanDepartment of Gynecology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Weihua JiaState Key Laboratory of Oncology in South China, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Xingjuan YuState Key Laboratory of Oncology in South China, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Rongzhen LuoDepartment of Pathology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Min ZhengDepartment of Gynecology, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangzhou, 510060, P. R. China.
Sun Yat-sen University · CNGuangdong Provincial People's Hospital · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreviously, we found an 11-gene signature could predict pelvic lymph node metastasis (PLNM), and WNT2 is one of the key genes in the signature. This study explored the expression and underlying mechanism of WNT2 in PLNM of cervical cancer.

methodsWNT2 expression level in cervical cancer was detected using western blotting, quantitative PCR, and immunohistochemistry. Two WNT2-specific small interfering RNAs (siRNAs) were used to explore the effects of WNT2 on invasive and metastatic ability of cancer cells, and to reveal the possible mechanism of WNT2 affecting epithelial-mesenchymal transition (EMT). The correlation between WNT2 expression and PLNM was further investigated in clinical cervical specimens.

resultsBoth WNT2 mRNA and protein expression was upregulated in cervical cancer. High WNT2 expression was significantly associated with tumor size, lymphovascular space involvement, positive parametrium, and most importantly, PLNM. PLNM and WNT2 expression were independent prognostic factors for overall survival and disease-free survival. WNT2 knockdown inhibited SiHa cell motility and invasion and reversed EMT by inhibiting the WNT2/β-catenin pathway. WNT2 overexpression in cervical cancer was associated with β-catenin activation and induction of EMT, which further contributed to metastasis in cervical cancer.

conclusionWNT2 might be a novel predictor of PLNM and a promising prognostic indicator in cervical cancer.

Indexed as

Cell MovementEpithelial-Mesenchymal Transitionbeta CateninBiomarkers, TumorCarcinoma, Squamous CellCase-Control StudiesCohort StudiesFemaleFollow-Up StudiesHumansImmunoenzyme TechniquesLymphatic MetastasisMiddle AgedNeoplasm GradingNeoplasm InvasivenessNeoplasm Stagingbeta CateninBiomarkers, TumorWnt2 ProteinWNT2 protein, human

Identifiers

PMID27513465
PMCPMC4981407
OpenAlexW2512048475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.